It was Su et al.'s 2019 Blood paper that was the precursor to the 2020 Cancer Cell paper: https://ashpublications.org/blood/article/134/Supplement_1/233/426136/Effective-Novel-Fto-Inhibitors-Show-Potent-Anti
However, the 2019 paper didn't identify that CS1 was bisantrene, that only happened in the 2020 paper.
- Forums
- ASX - By Stock
- RAC
- Pillar 1 - FTO (new thread)
Pillar 1 - FTO (new thread), page-2980
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.65 |
Change
-0.090(5.19%) |
Mkt cap ! $284.4M |
Open | High | Low | Value | Volume |
$1.71 | $1.71 | $1.65 | $22.54K | 13.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1882 | $1.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 193 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2509 | 1.635 |
4 | 11111 | 1.630 |
1 | 2500 | 1.625 |
4 | 8259 | 1.620 |
1 | 950 | 1.615 |
Price($) | Vol. | No. |
---|---|---|
1.655 | 193 | 1 |
1.660 | 8090 | 3 |
1.665 | 1271 | 2 |
1.670 | 1340 | 2 |
1.675 | 800 | 1 |
Last trade - 11.05am 24/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online